| 25/06/21 | NattoPharma ASA : - Delisting | AQ |
| 15/06/21 | NattoPharma : Received application for delisting | AQ |
| 14/06/21 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 10/06/21 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 09/06/21 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 08/02/2018 |
Robert Schrama
DFI | Director of Finance/CFO | - | 09/03/2020 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 04/11/2004 |
| Director/Board Member | 52 | 01/02/2011 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| +3.90% | +9.86% | +96.91% | +136.30% | 1,098B | |
| +0.99% | +2.91% | +51.05% | +52.06% | 631B | |
| +0.78% | +1.17% | +25.21% | +63.74% | 438B | |
| -0.35% | +4.80% | +51.42% | +39.79% | 368B | |
| +0.11% | +1.85% | +34.81% | +39.99% | 298B | |
| -0.71% | +4.26% | +9.78% | +7.42% | 251B | |
| +1.52% | +10.12% | +44.75% | +59.20% | 226B | |
| +0.91% | +1.27% | -5.23% | -50.94% | 209B | |
| -0.11% | +1.46% | +11.43% | +66.32% | 165B | |
| Average | +1.28% | +3.10% | +35.57% | +45.99% | 409.37B | |
| Weighted average by Cap. | +1.80% | +4.82% | +52.19% | +68.54% |
Employees
18
Sector
Pharmaceuticals
